Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy | |
Ma, Xiaodong[1]; Ozliseli, Ezgi[2]; Zhang, Yuezhou[3]; Pan, Guoqing[4]; Wang, Dongqing[5]; Zhang, Hongbo[6] | |
刊名 | BIOMATERIALS SCIENCE |
2019 | |
卷号 | 7期号:2页码:634-644 |
ISSN号 | 2047-4830 |
DOI | http://dx.doi.org/10.1039/c8bm01333k |
URL标识 | 查看原文 |
收录类别 | SCI(E) ; EI ; PUBMED |
WOS记录号 | WOS:000457525700014 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5325160 |
专题 | 江苏大学 |
作者单位 | 1.[1]Jiangsu Univ, Affiliated Hosp, Dept Radiol, Zhenjiang 212001, Peoples R China. 2.Abo Akad Univ, Fac Sci & Engn, Pharmaceut Sci Lab, FI-00520 Turku, Finland. 3.[2]Abo Akad Univ, Fac Sci & Engn, Pharmaceut Sci Lab, FI-00520 Turku, Finland. 4.[3]Abo Akad Univ, Fac Sci & Engn, Pharmaceut Sci Lab, FI-00520 Turku, Finland. 5.[4]Jiangsu Univ, Inst Adv Mat, Sch Mat Sci & Engn, 301Xuefu Rd, CN-212013 Zhenjiang, Jiangsu, Peoples R China. 6.[5]Jiangsu Univ, Affiliated Hosp, Dept Radiol, Zhenjiang 212001, Peoples R China. 7.[6]Jiangsu Univ, Affiliated Hosp, Dept Radiol, Zhenjiang 212001, Peoples R China. 8.Abo Akad Univ, Fac Sci & Engn, Pharmaceut Sci Lab, FI-00520 Turku, Finland. 9.Univ Turku, Turku Ctr Biotechnol, Turku, Finland.,Abo Akad Univ, Turku, Finland. |
推荐引用方式 GB/T 7714 | Ma, Xiaodong[1],Ozliseli, Ezgi[2],Zhang, Yuezhou[3],et al. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy[J]. BIOMATERIALS SCIENCE,2019,7(2):634-644. |
APA | Ma, Xiaodong[1],Ozliseli, Ezgi[2],Zhang, Yuezhou[3],Pan, Guoqing[4],Wang, Dongqing[5],&Zhang, Hongbo[6].(2019).Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy.BIOMATERIALS SCIENCE,7(2),634-644. |
MLA | Ma, Xiaodong[1],et al."Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy".BIOMATERIALS SCIENCE 7.2(2019):634-644. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论